Minnesota Oncology Hematology PA — Minneapolis, Minnesota

Minnesota Oncology Hematology PA is a clinical research site located in Minneapolis, Minnesota, United States 55404.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology PA has participated in 36 clinical trials with 10 currently active.

Therapeutic areas: Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, US Oncology Research, Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Minneapolis

Browse all research sites in Minnesota · View every site in Minneapolis

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology PA?

Minnesota Oncology Hematology PA has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology PA conducted?

Minnesota Oncology Hematology PA has 36 clinical trials on record, with 10 currently active. Their work covers Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck.

Is Minnesota Oncology Hematology PA accredited by Crixeo Clinical Trials?

Minnesota Oncology Hematology PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Oncology Hematology PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.